News 2012
12 Cities Project Evaluation Highlights Impacts on Coordination of HIV/AIDS Services
As readers may recall, the 12 Cities Project was undertaken as an element of the HHS National HIV/AIDS Strategy Operational Plan in “an effort to support comprehensive HIV/AIDS planning and cross-agency response in 12 communities hit hard by HIV/AIDS”.The project sought to advance the goals of the National HIV/AIDS Strategy (NHAS) by building on a funding opportunity announcement (FOA) released by the CDC in August 2010: “Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS (ECHPP).” The participating jurisdictions were: Atlanta; Baltimore; Chicago; Dallas; Washington, DC; Houston; Los Angeles; Miami; New York City; Philadelphia; San Juan, PR; and San Francisco.
Read more: 12 Cities Project Evaluation Highlights Impacts on Coordination of HIV/AIDS Services
Sickle Cell Disease Cuts HIV Risk in US Blacks: 400,000-Person Review
Sickle cell disease lowers the odds of HIV infection about 70%, according to analysis of 423,431 records of adult African-Americans admitted to the hospital from 1997 through 2009. In contrast, sickle cell disease raised chances of infection with hepatitis B or C virus (HBV or HCV).
Read more: Sickle Cell Disease Cuts HIV Risk in US Blacks: 400,000-Person Review
Black AIDS Institute Elects New Leadership
Dr. Neil Lowe Elected Chairman of the Black AIDS Institute Board of Directors
At its annual meeting on November 29, the Board of Directors of the Black AIDS Institute (the Institute) elected new officers to take on the challenges and opportunities in 2013 and lead the organization in a new strategic direction while continuing to tackle the HIV/AIDS epidemic in Black communities.
2012 Year in Review: 10 Stories That Affected HIV/AIDS in Black America, Part 1
Slightly more than 30 years into the HIV/AIDS epidemic, major breakthroughs in biomedical prevention continue to occur -- this year, most notably around pre-exposure prophylaxis (PrEP), which was found effective for both MSM and heterosexual couples and which the FDA approved for men. Significant improvements are also taking place in treatment and access to care, most notably related to the Affordable Care Act (ACA).
Read more: 2012 Year in Review: 10 Stories That Affected HIV/AIDS in Black America, Part 1
Unseen, Uncounted, and Undiagnosed Faces of Hepatitis C Virus
In 1981, as the HIV/AIDS epidemic emerged in the U.S., the medical and media communities focused on gay white men. Today, the face of HIV/AIDS is African American. This disease has taken far too many of our leaders and pioneers, moms and dads, sisters and brothers, and friends and confidantes.
Read more: Unseen, Uncounted, and Undiagnosed Faces of Hepatitis C Virus